GB1405444A - 2-aminoindane derivatives - Google Patents

2-aminoindane derivatives

Info

Publication number
GB1405444A
GB1405444A GB998773*[A GB998773A GB1405444A GB 1405444 A GB1405444 A GB 1405444A GB 998773 A GB998773 A GB 998773A GB 1405444 A GB1405444 A GB 1405444A
Authority
GB
United Kingdom
Prior art keywords
aminoindane derivatives
aminoindane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB998773*[A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MANUF PROD PHARMA
Original Assignee
MANUF PROD PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AR250138A priority Critical patent/AR206505A1/es
Application filed by MANUF PROD PHARMA filed Critical MANUF PROD PHARMA
Priority to GB998773*[A priority patent/GB1405444A/en
Priority to AU60283/73A priority patent/AU490246B2/en
Priority to IL43218A priority patent/IL43218A/en
Priority to CA180,979A priority patent/CA992547A/en
Priority to DE19732346337 priority patent/DE2346337C3/de
Priority to NL737312776A priority patent/NL152246B/xx
Priority to DD173520A priority patent/DD108277A5/xx
Priority to HUCI1409A priority patent/HU168018B/hu
Priority to CH1330973A priority patent/CH585690A5/xx
Priority to DD175711A priority patent/DD109802A5/xx
Priority to ES418827A priority patent/ES418827A1/es
Priority to LU68426A priority patent/LU68426A1/xx
Priority to MX146573U priority patent/MX3233E/es
Priority to FR7333497A priority patent/FR2199988B1/fr
Priority to JP10583673A priority patent/JPS5327263B2/ja
Priority to AR254382A priority patent/AR204247A1/es
Priority to AR252560A priority patent/AR208282A1/es
Priority to AR254383A priority patent/AR205891A1/es
Priority to ZA00741196A priority patent/ZA741196B/xx
Priority to IL44291A priority patent/IL44291A/en
Priority to JP49022702A priority patent/JPS5029541A/ja
Priority to LU69495A priority patent/LU69495A1/xx
Priority to AU66073/74A priority patent/AU486548B2/en
Priority to CA193,775A priority patent/CA997765A/en
Priority to CH283674A priority patent/CH587796A5/fr
Priority to ES423746A priority patent/ES423746A1/es
Priority to DD176870A priority patent/DD110649A5/xx
Priority to NL7402731A priority patent/NL7402731A/xx
Priority to HUCI1457A priority patent/HU167911B/hu
Priority to AT170474A priority patent/AT330166B/de
Priority to AR257533A priority patent/AR203500A1/es
Priority to AT512375A priority patent/AT336599B/de
Priority to ES440030A priority patent/ES440030A1/es
Priority to ES440029A priority patent/ES440029A1/es
Publication of GB1405444A publication Critical patent/GB1405444A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB998773*[A 1972-09-18 1973-03-01 2-aminoindane derivatives Expired GB1405444A (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
AR250138A AR206505A1 (es) 1972-09-18 1973-01-01 Procedimiento para obtener nuevos derivados de n-fenil-n-aminoalquil-2-aminoindano
GB998773*[A GB1405444A (en) 1972-09-18 1973-03-01 2-aminoindane derivatives
AU60283/73A AU490246B2 (en) 1972-09-18 1973-09-13 New derivatives of 2 amino-indane, the preparation andthe use thereof
IL43218A IL43218A (en) 1972-09-18 1973-09-13 2-n-phenyl-n-aminoalkyl-aminoindanes their preparation and pharmaceutical compositions containing them
CA180,979A CA992547A (en) 1972-09-18 1973-09-14 Derivatives of 2-aminoindane, the preparation and use thereof
DE19732346337 DE2346337C3 (de) 1972-09-18 1973-09-14 N-Alkylamino-Derivate des 2-Aminoindans, ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DD173520A DD108277A5 (sv) 1972-09-18 1973-09-17
NL737312776A NL152246B (nl) 1972-09-18 1973-09-17 Werkwijze voor het bereiden van een preparaat met anti-aritmische activiteit, gevormd preparaat en werkwijze voor het bereiden van een daartoe geschikte verbinding.
HUCI1409A HU168018B (sv) 1972-09-18 1973-09-17
CH1330973A CH585690A5 (sv) 1972-09-18 1973-09-17
DD175711A DD109802A5 (sv) 1972-09-18 1973-09-17
ES418827A ES418827A1 (es) 1972-09-18 1973-09-17 Un procedimiento para preparar nuevos derivados 2-aminoinda-no.
LU68426A LU68426A1 (sv) 1972-09-18 1973-09-17
MX146573U MX3233E (es) 1972-09-18 1973-09-18 Procedimiento para preparar derivados de 2 - amino indano
FR7333497A FR2199988B1 (sv) 1972-09-18 1973-09-18
JP10583673A JPS5327263B2 (sv) 1972-09-18 1973-09-18
AR252560A AR208282A1 (es) 1973-03-01 1974-01-01 Procedimiento para preparar derivados del 2-(n-fenil-(-aminoalquil)-aminoindano
AR254382A AR204247A1 (es) 1972-09-18 1974-01-01 Procedimiento para preparar nuevos derivados de 2-amino(alquil o hidroxialquil)-aminoindano
AR254383A AR205891A1 (es) 1972-09-18 1974-01-01 Procedimiento para preparar compuestos derivados de n-(aminoalquil)-2-aminoindano
ZA00741196A ZA741196B (en) 1973-03-01 1974-02-22 Process for preparing derivatives of 2-aminoindane
IL44291A IL44291A (en) 1973-03-01 1974-02-26 Preparation of 2-aminoindane derivatives
JP49022702A JPS5029541A (sv) 1973-03-01 1974-02-26
LU69495A LU69495A1 (sv) 1973-03-01 1974-02-27
AU66073/74A AU486548B2 (en) 1973-03-01 1974-02-27 Process for preparing derivatives of 2-aminoindane
DD176870A DD110649A5 (sv) 1973-03-01 1974-02-28
CH283674A CH587796A5 (en) 1973-03-01 1974-02-28 2-Aminoalkyl amino indanes - anti-arrhythmic,orally active, long-acting, not myocardial depressant
ES423746A ES423746A1 (es) 1973-03-01 1974-02-28 Procedimiento para preparar derivados de 2-aminoindano.
CA193,775A CA997765A (en) 1973-03-01 1974-02-28 Derivatives of 2-amino-indane, the preparation and use thereof
NL7402731A NL7402731A (sv) 1973-03-01 1974-02-28
HUCI1457A HU167911B (sv) 1973-03-01 1974-02-28
AT170474A AT330166B (de) 1973-03-01 1974-03-01 Verfahren zur herstellung von neuen 2-aminoindanderivaten
AR257533A AR203500A1 (es) 1972-09-18 1975-02-05 Procedimiento para preparar nuevos derivados de n-aminoalquil-2-aminoindano
AT512375A AT336599B (de) 1973-03-01 1975-07-03 Verfahren zur herstellung von neuen 2-aminoindan-derivaten
ES440030A ES440030A1 (es) 1972-09-18 1975-08-05 Un procedimiento para preparar nuevos derivados de 2-ami- noindano.
ES440029A ES440029A1 (es) 1972-09-18 1975-08-05 Un procedimiento para preparar nuevos derivados de 2-ami- noindano.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4315072 1972-09-18
GB998773*[A GB1405444A (en) 1972-09-18 1973-03-01 2-aminoindane derivatives
GB998873 1973-03-01
GB1030373 1973-03-02

Publications (1)

Publication Number Publication Date
GB1405444A true GB1405444A (en) 1975-09-10

Family

ID=27447738

Family Applications (1)

Application Number Title Priority Date Filing Date
GB998773*[A Expired GB1405444A (en) 1972-09-18 1973-03-01 2-aminoindane derivatives

Country Status (13)

Country Link
JP (1) JPS5327263B2 (sv)
AR (4) AR206505A1 (sv)
CA (1) CA992547A (sv)
CH (1) CH585690A5 (sv)
DD (2) DD109802A5 (sv)
ES (3) ES418827A1 (sv)
FR (1) FR2199988B1 (sv)
GB (1) GB1405444A (sv)
HU (1) HU168018B (sv)
IL (1) IL43218A (sv)
LU (1) LU68426A1 (sv)
MX (1) MX3233E (sv)
NL (1) NL152246B (sv)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2191999A (en) * 1986-06-19 1987-12-31 Squibb & Sons Inc p-Aminophenols, derivatives thereof and method of use
EP1185267A1 (en) * 1999-06-10 2002-03-13 Bridge Pharma, Inc. Dermal anesthetic agents
US6703421B1 (en) 1999-09-17 2004-03-09 Daiichi Suntory Pharma Co., Ltd. Methods of using phenylmethylbenzoquinone and hydroquinone compounds for treatment of myocarditis, dilated cardiomyopathy and heart failure
US6787570B2 (en) 1999-09-23 2004-09-07 Pfizer, Inc. Substituted N-cycloalkyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
EP1658847A2 (en) * 1999-06-10 2006-05-24 Bridge Pharma, Inc. Indane derivatives as dermal anesthetic agents
US7592458B2 (en) 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0293610U (sv) * 1989-01-09 1990-07-25

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2191999A (en) * 1986-06-19 1987-12-31 Squibb & Sons Inc p-Aminophenols, derivatives thereof and method of use
EP1185267A1 (en) * 1999-06-10 2002-03-13 Bridge Pharma, Inc. Dermal anesthetic agents
EP1185267A4 (en) * 1999-06-10 2003-09-03 Bridge Pharma Inc DERMAL ANESTHETIC AGENTS
EP1658847A2 (en) * 1999-06-10 2006-05-24 Bridge Pharma, Inc. Indane derivatives as dermal anesthetic agents
EP1658847A3 (en) * 1999-06-10 2006-07-26 Bridge Pharma, Inc. Indane derivatives as dermal anesthetic agents
US6703421B1 (en) 1999-09-17 2004-03-09 Daiichi Suntory Pharma Co., Ltd. Methods of using phenylmethylbenzoquinone and hydroquinone compounds for treatment of myocarditis, dilated cardiomyopathy and heart failure
US6787570B2 (en) 1999-09-23 2004-09-07 Pfizer, Inc. Substituted N-cycloalkyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US7592458B2 (en) 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain

Also Published As

Publication number Publication date
FR2199988B1 (sv) 1977-11-25
AR205891A1 (es) 1976-06-15
DD109802A5 (sv) 1974-11-20
AR206505A1 (es) 1976-07-30
IL43218A (en) 1977-05-31
ES440029A1 (es) 1977-02-16
IL43218A0 (en) 1973-11-28
DE2346337A1 (de) 1974-04-04
HU168018B (sv) 1976-02-28
ES418827A1 (es) 1977-02-01
NL152246B (nl) 1977-02-15
JPS5327263B2 (sv) 1978-08-07
AR204247A1 (es) 1975-12-10
AU6028373A (en) 1975-03-13
MX3233E (es) 1980-08-05
JPS4969648A (sv) 1974-07-05
CA992547A (en) 1976-07-06
CH585690A5 (sv) 1977-03-15
NL7312776A (sv) 1974-03-20
DE2346337B2 (de) 1976-08-26
FR2199988A1 (sv) 1974-04-19
AR203500A1 (es) 1975-09-15
LU68426A1 (sv) 1973-11-26
DD108277A5 (sv) 1974-09-12
ES440030A1 (es) 1977-02-16

Similar Documents

Publication Publication Date Title
IL43795A (en) 3-aminoalkylamino-1-phenoxy-2-propanol derivatives
ZA728544B (en) Alpha-aryl-4-substituted piperidinoalkanol derivatives
ZA736059B (en) New quinoxaline-di-n-oxide derivatives
CY992A (en) Benzocycloheptathiophene derivatives
GB1402219A (en) Berbine derivatives
GB1405444A (en) 2-aminoindane derivatives
IL42943A (en) 16-methyl-prednisolone derivatives
ZA728917B (en) Oxaziniondole-and thiaziniondole derivatives
IL43280A0 (en) Amidinourea derivatives
PH10465A (en) Debenzazecine derivatives
IL41789A (en) Diphenylalkyllactamimide derivatives
KE2917A (en) New phenylformamidine derivatives
GB1405227A (en) Pheynlthioethyl-imidazole derivatives
AU7256574A (en) Benzophenone derivatives
KE2814A (en) Tricyclic disphenylamine derivatives
ZA734945B (en) New beta-aminoketone derivatives
ZA728875B (en) Pyrano-and thiopyranoindole derivatives
AU5719473A (en) Diphenylmethane derivatives
IL43667A0 (en) Fluorene derivatives
PH10653A (en) Indolylimidoylquinoline derivatives
MY8000220A (en) Benzoisoindoline derivatives
AU5423773A (en) Alpha-pyrone derivatives
PH10601A (en) Diaza-oxa-bicyclodecane derivatives
AU5872373A (en) Isoxolidine derivatives
AU5916873A (en) Cyclohexanepentol derivative

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee